Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.615 CAD | -3.51% | +5.44% | +52.03% |
May. 14 | Toronto Stocks Edge Down; Hudbay Minerals Rises on 1Q Earnings Beat | DJ |
May. 14 | Transcript : Organigram Holdings Inc., Q2 2024 Earnings Call, May 14, 2024 |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+54.07% | 206M | C | ||
-.--% | 339M | - | - | |
+43.62% | 299M | - | ||
+23.71% | 279M | - | ||
+161.28% | 154M | - | - | |
+45.35% | 132M | - | ||
-42.86% | 122M | - | - | |
-42.66% | 119M | C | ||
+7.69% | 118M | - | - | |
+50.00% | 60.26M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- OGI Stock
- Ratings Organigram Holdings Inc.